Comparison of Early and Late Fetal Extraction on Maternal Outcome in Placenta Accreta Spectrum
Keywords:
Placenta Accreta, Early Fetal Extraction, Late Fetal Extraction, Neonatal OutcomesAbstract
Background: Placenta accreta spectrum (PAS) is one of the devastating obstetric complications owing to massive bleeding that may lead to peripartum hysterectomy, need for massive blood transfusion, maternal intensive care admission and maternal mortality. The aim of this work was to investigate the effect of late fetal extraction on the maternal and neonatal outcomes in patients diagnosed with PAS.
Methods: This prospective cohort study was carried out on 60 pregnant women with age from 18 to 40 years old with PAS diagnosed by ultrasound, operative findings and histopathological examination. Patients were divided into two equal groups: Group (A): Late fetal extraction and Group (B): Early fetal extraction.
Results: Time from induction of anesthesia to peritoneal entry and from peritoneal entry till cord clamping were significantly higher in group (A) than group (B) (P <0.001). Blood loss, blood transfusion and bladder injuries were significantly lower in group (A) compared to group (B) (P<0.05). Hospital stay and intensive care unit admission were insignificantly different between both groups. In both groups no cases of maternal mortalities, the estimated fetal weight, APGAR score at 1 min and 5 min, neonatal intensive care unit and neonatal respiratory support were insignificantly different between both groups.
Conclusions: The late fetal extraction technique was superior to early fetal extraction as it showed lower blood loss, blood transfusion and lower bladder injury for cases with PAS without affecting neonatal outcome.
Downloads
Metrics
References
Neville G, Carusi D, Hope YY, Sharma A, Quade BJ, Parra-Herran C. Placenta accreta spectrum: Evaluation of classic and non-classic presentations, pathologic grading, and uterine scar dehiscence features in a modern institutional series. Placenta. 2024;146:64-70.
Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta. Am J Obstet Gynecol. 1966;95:660-8.
Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24:1341-6.
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75-87.
Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010;115:65-9.
Bayo AI, Babarinsa I, Jido TA, Al Obaidly S, Shahata MA. Peripartum Hemorrhage: Recent Updates in Management. Updates in Intensive Care of OBGY Patients. 178. 2nd ed: Springer; 2024. p. 73-105.
Friedrich L, Mor N, Weissmann‐Brenner A, Kassif E, Friedrich SN, Weissbach T, et al. Risk factors for bladder injury during placenta accreta spectrum surgery. Int J Gynecol Obstet. 2023;161:911-9.
Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212:561-8.
Hussein AM, Kamel A, Elbarmelgy RA, Thabet MM, Elbarmelgy RM. Managing placenta accreta spectrum disorders (PAS) in middle/low-resource settings. Curr Obstet Gynecol. 2019;8:71-9.
Hussein AM, Momtaz M, Elsheikhah A, Abdelbar A, Kamel A. The role of ultrasound in prediction of intra-operative blood loss in cases of placenta accreta spectrum disorders. Arch Gynecol Obstet. 2020;302:1143-50.
Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47:271-5.
Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG. 2019;126:44-9.
EBL EBL. Quantification of blood loss: AWHONN practice brief number. Miscellaneous. 2015;98:158-60.
Bellieni CV. Apgar score-it is time to avoid pain. JAMA Pediatr. 2021;175:206-7.
Youssef YA, Farghaly TA, Elsenosy E, Youssef AA, Abbas AM. The effect of omission of the bladder flap formation at lower segment cesarean delivery: a randomized controlled trial. Open J Obstet Gynecol. 2019;9:1083-96.
Hussein AM, Kamel A, Raslan A, Dakhly DMR, Abdelhafeez A, Nabil M, et al. Modified cesarean hysterectomy technique for management of cases of placenta increta and percreta at a tertiary referral hospital in Egypt. Arch Gynecol Obstet. 2019;299:695-702.
Am Ahmed M, Khodry MM. Modified Triple P approach by gynecologic oncologist-led team for placenta accreta spectrum improves the outcome: a non-randomized controlled trial. Open J Obstet Gynecol 2019;9:1039-49.
Varlas VN, Bors RG, Birsanu S, Maxim B, Clotea E, Mihailov M. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center. J Med Life. 2021;14:367-75.
Zhong W, Zhu F, Li S, Chen J, He F, Xin J, et al. Maternal and neonatal outcomes after planned or emergency delivery for placenta accreta spectrum: A systematic review and meta-analysis. Front Med (Lausanne). 2021;8:731-4.
Bluth A, Schindelhauer A, Nitzsche K, Wimberger P, Birdir C. Placenta accreta spectrum disorders-experience of management in a German tertiary perinatal centre. Arch Gynecol Obstet. 2021;303:1451-60.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
